These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36372074)

  • 1. WHO Living Guidelines on antivirals for COVID-19 are evidence-based.
    Owen A; Diaz JV; Guyatt G; Lamontagne F; Stegemann M; Vandvik PO; Agoritsas T
    Lancet; 2022 Dec; 400(10369):2196-2198. PubMed ID: 36372074
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral antiviral treatments for COVID-19: opportunities and challenges.
    Rahmah L; Abarikwu SO; Arero AG; Essouma M; Jibril AT; Fal A; Flisiak R; Makuku R; Marquez L; Mohamed K; Ndow L; Zarębska-Michaluk D; Rezaei N; Rzymski P
    Pharmacol Rep; 2022 Dec; 74(6):1255-1278. PubMed ID: 35871712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update to living WHO guideline on drugs for covid-19.
    BMJ; 2021 Sep; 374():n2219. PubMed ID: 34556469
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy.
    Mirtaleb MS; Mirtaleb AH; Nosrati H; Heshmatnia J; Falak R; Zolfaghari Emameh R
    Biomed Pharmacother; 2021 Jun; 138():111518. PubMed ID: 33774315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventilatory support and corticosteroid therapy in SARS-CoV-2.
    Martínez Sagasti F; Palazón Blanco A; García-Perrote SC; Alonso Martínez P
    Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):52-56. PubMed ID: 34598428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No shortcuts to SARS-CoV-2 antivirals.
    Edwards A; Hartung IV
    Science; 2021 Jul; 373(6554):488-489. PubMed ID: 34326222
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 and the Functionality of Antivirals: The Day After Tomorrow.
    Sharifan A
    Health Secur; 2022; 20(3):270-271. PubMed ID: 35723880
    [No Abstract]   [Full Text] [Related]  

  • 8. Current Perspective of Antiviral Strategies against COVID-19.
    Ahidjo BA; Loe MWC; Ng YL; Mok CK; Chu JJH
    ACS Infect Dis; 2020 Jul; 6(7):1624-1634. PubMed ID: 32485102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update to living WHO guideline on drugs for covid-19.
    BMJ; 2020 Dec; 371():m4779. PubMed ID: 33334781
    [No Abstract]   [Full Text] [Related]  

  • 10. Newer oral antivirals for COVID-19: Are they the real game changer?
    Kunal S; Sakthivel P; Malhotra N; Ish P
    Heart Lung; 2022; 52():200-203. PubMed ID: 35078637
    [No Abstract]   [Full Text] [Related]  

  • 11. A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics.
    Prathiviraj R; Saranya S; Bharathi M; Chellapandi P
    Comput Biol Med; 2021 May; 132():104315. PubMed ID: 33705994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pandemic of Coronavirus Disease 2019 (COVID-19).
    Rashid NN
    Curr Mol Med; 2022; 22(9):761-765. PubMed ID: 34789125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
    Canedo-Marroquín G; Saavedra F; Andrade CA; Berrios RV; Rodríguez-Guilarte L; Opazo MC; Riedel CA; Kalergis AM
    Front Immunol; 2020; 11():569760. PubMed ID: 33362758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine.
    Guan W; Lan W; Zhang J; Zhao S; Ou J; Wu X; Yan Y; Wu J; Zhang Q
    Virol Sin; 2020 Dec; 35(6):685-698. PubMed ID: 32997322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic and therapeutic topical povidone-iodine in coronavirus disease 2019 (COVID-19): What is the evidence?
    Yan CH; Bleier BS
    Int Forum Allergy Rhinol; 2020 Dec; 10(12):1271-1273. PubMed ID: 33118690
    [No Abstract]   [Full Text] [Related]  

  • 16. Current development of COVID-19 diagnostics, vaccines and therapeutics.
    Zhang N; Li C; Hu Y; Li K; Liang J; Wang L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):231-235. PubMed ID: 32387332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials with antiviral drugs against COVID-19: some progress and many shattered hopes.
    Brüssow H
    Environ Microbiol; 2021 Nov; 23(11):6364-6376. PubMed ID: 34519154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.
    Abdel-Moneim AS; Abdelwhab EM; Memish ZA
    Virology; 2021 Jun; 558():1-12. PubMed ID: 33691216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus disease 2019 (COVID-19) oral antivirals stewardship: Establishing game rules.
    Mazonakis N; Tsioutis C; Markaki I; Papadakis M; Papadakos S; Spernovasilis N
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1990-1992. PubMed ID: 35115067
    [No Abstract]   [Full Text] [Related]  

  • 20. Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options for COVID-19.
    Sutanto ST; Sinto R; Pasaribu A; Shakinah S
    Acta Med Indones; 2022 Oct; 54(4):638-644. PubMed ID: 36624705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.